VIM and prostate cancer: It is also worth noting that the absence of the expression of a key marker of prostate cancer stem cells, Integrin α2β1, in vimentin-positive cells in clone P4B6, may support the observation made by Celià-Terrassa et al., that EMT can suppress major attributes of epithelial tumour-initiating cells63.